长城港股医疗保健精选混合发起(QDII)C
Search documents
11/21财经夜宵:得知基金净值排名及选基策略,赶紧告知大家
Sou Hu Cai Jing· 2025-11-21 15:40
Group 1 - The article provides an objective ranking of fund net values, highlighting the top-performing and bottom-performing funds without subjective bias [1] - The top 10 funds with the highest net value growth include: Changcheng Hong Kong Medical Healthcare Selected Mixed Fund (QDII) C, Changcheng Hong Kong Medical Healthcare Selected Mixed Fund (QDII) A, and others [2] - The bottom 10 funds with the lowest net value growth include: Furong Fuxin Mixed Fund A, Furong Fuxin Mixed Fund C, and others [3] Group 2 - The Shanghai Composite Index opened lower and declined, closing with a significant drop, while the ChiNext Index showed a similar downward trend [5] - The leading sectors included shipbuilding, while the lagging sectors were communication equipment, comprehensive categories, mineral products, non-ferrous metals, and chemicals, all experiencing declines of over 5% [5] - The fund with the fastest net value growth is identified as Changcheng Hong Kong Medical Healthcare Selected Mixed Fund (QDII) C [5] Group 3 - The top holdings of the Changcheng Hong Kong Medical Healthcare Selected Mixed Fund include companies like He Yu Cayman Limited and He Bo Pharmaceutical Holdings, with a concentration of 66.08% in the top ten holdings [6] - The fund's style is oriented towards the pharmaceutical industry, and it has outperformed the market [6] - The top holdings of the Furong Fuxin Mixed Fund show a concentration of 49.54%, with significant declines in stocks like Tian Tie Technology and Lian Ying Laser [6]